Eagle Bay Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599K Buy
651
+28
+4% +$28.4K 0.53% 44
2025
Q4
$669K Sell
623
-16
-3% -$15.3K 0.49% 39
2025
Q3
$487K Sell
639
-116
-15% -$86.3K 0.38% 50
2025
Q2
$588K Buy
755
+23
+3% +$17.9K 0.49% 45
2025
Q1
$604K Buy
732
+26
+4% +$21.6K 0.51% 45
2024
Q4
$545K Sell
706
-78
-10% -$64.6K 0.34% 51
2024
Q3
$694K Buy
784
+19
+2% +$17.1K 0.27% 69
2024
Q2
$692K Sell
765
-159
-17% -$127K 0.42% 40
2024
Q1
$718K Buy
924
+380
+70% +$270K 0.45% 41
2023
Q4
$317K Sell
544
-19
-3% -$11.1K 0.2% 87
2023
Q3
$302K Buy
563
+12
+2% +$6.18K 0.14% 107
2023
Q2
$258K Buy
551
+11
+2% +$4.61K 0.15% 98
2023
Q1
$185K Sell
540
-39
-7% -$13.2K 0.1% 141
2022
Q4
$212K Sell
579
-161
-22% -$57.1K 0.12% 128
2022
Q3
$240K Sell
740
-9
-1% -$2.85K 0.15% 105
2022
Q2
$243K Buy
+749
New +$225K 0.15% 109
2022
Q1
Sell
-764
Closed -$212K 658
2021
Q4
$212K Sell
764
-657
-46% -$167K 0.14% 97
2021
Q3
$328K Buy
1,421
+385
+37% +$95K 0.18% 80
2021
Q2
$241K Buy
+1,036
New +$208K 0.19% 72

Other funds holding LLY

Eagle Bay Advisors's LLY Position: Q1 2026 in Review

Eagle Bay Advisors increased its Eli Lilly (LLY) stake by 4.5% in Q1 2026, buying an estimated $28.4K and bringing the position to 651 shares worth $599K. The position accounts for 0.53% of the portfolio, ranked #44.

Eagle Bay Advisors first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $718K in Q1 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Eagle Bay Advisors held 651 shares of Eli Lilly worth $599K as of Q1 2026.
  • Eagle Bay Advisors bought 28 Eli Lilly shares in Q1 2026, an estimated $28.4K.
  • Eli Lilly made up 0.53% of Eagle Bay Advisors's portfolio in Q1 2026, its #44 holding.
  • Eagle Bay Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
  • Eagle Bay Advisors's Eli Lilly position peaked at $718K in Q1 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.